Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 12;57(9):962.
doi: 10.3390/medicina57090962.

The Influence of Maternal Obesity on Cell-Free Fetal DNA and Blood Pressure Regulation in Pregnancies with Hypertensive Disorders

Aleksandra Stupak  1 , Wojciech Kwaśniewski  2 , Anna Goździcka-Józefiak  3 , Anna Kwaśniewska  1
Affiliations

The Influence of Maternal Obesity on Cell-Free Fetal DNA and Blood Pressure Regulation in Pregnancies with Hypertensive Disorders

Aleksandra Stupak et al. Medicina (Kaunas). .

Abstract

Background and Objectives: obesity and blood pressure disorders are one of the main risk factors for antenatal, intra, postpartum, and neonatal complications. In preeclampsia (PE), the placental hypoxia leads to vascular endothelium dysfunction, cell necrosis, and apoptosis. This condition is associated with the release of free fetal DNA (cffDNA) circulating in plasma. The disturbance of the efficiency of vasodilatation and blood pressure regulation in PE can be confirmed by analyzing the apelin, salusin, and prosalusin. This study aimed to assess the influence of obesity on cffDNA, and the effectiveness of maintaining normal blood pressure in patients with preeclampsia and gestational hypertension. Material and Methods: the research material was blood serum and oral mucosa swabs, obtained from 168 patients. Pregnant women were divided into the following: a control group (C)-67 women; a gestational hypertension group (GH)-35 patients; a preeclampsia with obesity group (PE + O) (pre-gravid BMI > 30)-23 patients. The rest were lean preeclamptic women (PE)-66 patients-(pre-gravid BMI < 25 in 43 women). Results: the cffDNA was observed in 1.50% of women in the C group, in 2.45% in the GH group, but in 18.18% of lean patients with preeclampsia. The cffDNA was detected in 58% of obese pregnant women with PE. The greater the placental hypoxia was in preeclampsia, the less efficient the hypotensive mechanisms, according to an analysis of the studied adipokines. The prosalusin concentration was significantly lower in the PE group with cffDNA than in the PE group without it (p = 0.008). Apelin was higher in the PE group with cffDNA (p = 0.006) compared to other groups. The same results were also observed in the subgroup with obesity. Conclusion: in preeclamptic women, obesity seems to act as an additive factor of placental damage by means of the dysregulation of hypotensive mechanisms.

Keywords: apelin; cell-free fetal DNA; hypertension; obesity; placenta; preeclampsia; prosalusin; salusin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Results of assessing the occurrence of cffDNA in pregnant plasma.
Figure 2
Figure 2
Prosalusin values between pregnant women in studied groups, p = 0.00001.
Figure 3
Figure 3
Salusin-alpha values in pregnant women between the examined groups, p = 0.003.
Figure 4
Figure 4
Apelin values between pregnant women in all groups, p = 0.007.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ballesta-Castillejos A., Gómez-Salgado J., Rodríguez-Almagro J., Ortiz-Esquinas I., Hernández-Martínez A. Relationship between Maternal Body Mass Index and Obstetric and Perinatal Complications. J. Clin. Med. 2020;9:707. doi: 10.3390/jcm9030707. - DOI - PMC - PubMed
    1. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., Kawamata Y., Fukusumi S., Hinuma S., Kitada C., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 1998;251:471–476. doi: 10.1006/bbrc.1998.9489. - DOI - PubMed
    1. Cobellis L., De Falco M., Mastrogiacomo A., Giraldi D., Dattilo D., Scaffa C., Colacurci N., De Luca A. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histol. Histopathol. 2007;22:1–8. - PubMed
    1. Bortoff K.D., Qiu C., Runyon S., Williams M.A., Maitra R. Decreased maternal plasma apelin concentrations in preeclampsia Hypertens. Pregnancy. 2012;31:398–404. doi: 10.3109/10641955.2012.690054. - DOI - PubMed
    1. Farid R.M., Abu-Zeid R.M., El-Tawil A. Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients. Int. J. Clin. Exp. Pathol. 2014;7:2707–2717. - PMC - PubMed